Parenteral administration of recombinant human neuregulin-1 to patients with stable chronic heart failure produces favourable acute and chronic haemodynamic responses

Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers

(2010) Claes-Håkan Bergh et al.   EUROPEAN JOURNAL OF HEART FAILURE

Neuregulin1/ErbB4 Signaling Induces Cardiomyocyte Proliferation and Repair of Heart Injury

(2009) Kevin Bersell et al.   CELL

Neuregulin-1β Is Associated With Disease Severity and Adverse Outcomes in Chronic Heart Failure

(2009) Bonnie Ky et al.   CIRCULATION

HB-EGF-induced VEGF production and eNOS activation depend on both PI3 kinase and MAP kinase in HaCaT cells

(2009) Kozo Nakai et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

Sympathetic Nervous System Activation in Human Heart Failure

(2009) John S. Floras   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Identification of Cardiac-Specific Myosin Light Chain Kinase

(2008) Jason Y. Chan et al.   CIRCULATION RESEARCH

Clinical significance of chemosensitivity in chronic heart failure: influence on neurohormonal derangement, Cheyne–Stokes respiration and arrhythmias

(2008) Alberto Giannoni et al.   CLINICAL SCIENCE

Neuregulin-1/ErbB signaling: a druggable target for treating heart failure

(2008) Yabei Xu et al.   CURRENT OPINION IN PHARMACOLOGY